Attovia Therapeutics, Inc.

ATTO

Insiders bought in the last twelve months.

13.73 1.05 −7.10%
Market cap
$674.7M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Dec '25
Cash and Short Term Investments
115.13 152.27
Total current assets
118.40 156.30
Property, Plant, Equpment (Net)
3.34 3.49
Long-term assets (Other)
3.03 1.73
Total non-current assets
9.95 9.60
Total Assets
128.35 165.89
Accounts Payable
6.00 3.55
Accrued Expenses
4.58 5.54
Total current liabilities
12.62 11.01
Liabilities (Preferred Stock)
258.23 258.23
Non-current Liabilities (Other)
0.68 0.76
Total non-current liabilities
261.19 262.32
Total liabilities
273.81 273.33
Additional Paid In Capital
4.97 3.47
Common Stock (Net)
0.00 0.00
Retained Earnings
(150.35) (111.01)
Common Equity (Total)
(145.46) (107.44)
Shareholders Equity (Total)
(145.46) (107.44)
Shareholders Equity and Liabilities (Total)
128.35 165.89
Shares (Common)
4.53 4.51
Shareholders Equity (Tangible)
(145.46) (107.44)
Net Debt
(115.13) (152.27)

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 29 Sep 2026